Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
09/11/2002 | CN1368380A Chinese medicine for treating hepatitis B and its preparing process |
09/11/2002 | CN1368378A Efficient medicine for treating foot tinea and berberi |
09/11/2002 | CN1368373A Chinese medicine for treating bone tuberculosis, osteomyelitis, phlebitis and organism ulceration |
09/11/2002 | CN1368361A Nano medicine 'Xiaoer Jingan' and its preparing process |
09/11/2002 | CN1368345A Nano medicine 'Junliping' and its preparing process |
09/11/2002 | CN1368337A Nano medicine 'Wanbao' and its preparing process |
09/11/2002 | CN1368330A Nano medicine 'Yanreqing' and its preparing process |
09/11/2002 | CN1368325A Nano medicine 'Zhimiling' and its preparing process |
09/11/2002 | CN1368312A Nano medicine 'Wanxuanjing' and its preparing process |
09/11/2002 | CN1368304A Nano medicine 'Yinchai' and its preparing process |
09/11/2002 | CN1368302A Nano medicine for treating infantile dysentery and its preparing process |
09/11/2002 | CN1368294A Nano medicine 'Xihuang' and its preparing process |
09/11/2002 | CN1368289A Nano medicine 'Shexiang Qiying' and its preparing process |
09/11/2002 | CN1368288A Nano medicine 'Shexiang Sanmiao' and its preparing process |
09/11/2002 | CN1368275A Nano medicine 'Zhike Taohua' and its preparing process |
09/11/2002 | CN1368273A Nano medicine 'Zhenzhu Niuhuang' and its preparing process |
09/11/2002 | CN1368269A Nano medicine 'Shaxi' and its preparing process |
09/11/2002 | CN1368266A Nano medicine 'Xuedansu' and its preparing process |
09/11/2002 | CN1368261A Nano medicine 'Xiaoyanjiedu' and its preparing process |
09/11/2002 | CN1368258A Nano medicine 'Zhongjiefeng' and its preparing process |
09/11/2002 | CN1368243A Nano medicine 'Pediatric Qili' and its preparing process |
09/11/2002 | CN1368242A Nano medicine 'Fuyankang' and its preparing process |
09/11/2002 | CN1368228A Nano medicine 'Baihua' and its preparing process |
09/11/2002 | CN1368214A Nano medicine 'Compound satis Leaf' and its preparing process |
09/11/2002 | CN1368206A Nano medicine 'Zhizi Jinhua' and its preparing process |
09/11/2002 | CN1368179A Nano medicine 'Shexiangqutong' and its preparing process |
09/11/2002 | CN1368176A Nano medicine 'Reyanning' and its preparing process |
09/11/2002 | CN1368174A Nano medicine for treating measles and its preparing process |
09/11/2002 | CN1368163A Nano medicine 'Jinglingganmao' and its preparing process |
09/11/2002 | CN1368162A Nano medicine 'Jingangteng' and its preparing process |
09/11/2002 | CN1368148A Nano medicine for treating tuberculosis and its preparing process |
09/11/2002 | CN1368132A Nano musk medicine and its preparing process |
09/11/2002 | CN1368127A Nano medicine 'Liandanxiaoyan' and its preparing process |
09/11/2002 | CN1368124A Nano medicine for treating stomatitis and its preparing process |
09/11/2002 | CN1368123A Nano medicine 'Kanggongyan' and its preparing process |
09/11/2002 | CN1368122A Nano antivirus medicine and its preparing process |
09/11/2002 | CN1368114A Nano medicine 'Yajiaohadun' and its preparing process |
09/11/2002 | CN1368104A Nano medicine 'Xiaoerqingjie' and its preparing process |
09/11/2002 | CN1368101A Nano medicine 'Xiaobaidu' and its preparing process |
09/11/2002 | CN1368097A Nano medicine for treating lupus and its preparing process |
09/11/2002 | CN1368093A Nano medicine 'Luxue' and its preparing process |
09/11/2002 | CN1368085A Nano medicine 'Niuhuang Xiling' and its preparing process |
09/11/2002 | CN1368084A Nano medicine 'Penyanjing' and its preparing process |
09/11/2002 | CN1368083A Nano medicine 'Pianzaihuang' and its preparing process |
09/11/2002 | CN1368065A Nano medicine 'Saixianning' and its preparing process |
09/11/2002 | CN1368060A Nano defervescent and digestion-promoting medicine and its preparing process |
09/11/2002 | CN1368057A Nano medicine 'Qingyan' and its preparing process |
09/11/2002 | CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
09/11/2002 | CN1090506C Application of lysozyme dimer |
09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
09/11/2002 | CN1090493C Chiense medicine preparation for pulmonary tuberculosis and its preparation method |
09/11/2002 | CN1090492C Ointment for treating skin tinea |
09/10/2002 | US6448393 Deprotecting carboxylic acid group, dehalogenating and sulfiding with heteroaryl-thio substituted compound producing 3-thiomethylcephem compounds; chemical intermediates to antibiotics, such as cefazolin and ceftriaxone |
09/10/2002 | US6448386 High molecular weight major outer membrane protein of moraxella |
09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
09/10/2002 | US6448376 Two new proteins which appear to be new members of the e2f gene family, called e2f-5 |
09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
09/10/2002 | US6448284 Substituted tricyclics |
09/10/2002 | US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c |
09/10/2002 | US6448271 Substituted benzimidazoles and their use as parp inhibitors |
09/10/2002 | US6448266 Substituted cyclobutylamine derivatives |
09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
09/10/2002 | US6448256 Precursors of n-substituted derivatives of 6-aminouracils, 6-aminoisocytosines, guanines and 2-aminoadenines having a cleavable ester group; greater water solubility and oral bioavailability; treating gram positive bacterial infections |
09/10/2002 | US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually |
09/10/2002 | US6448236 Functional agonists of the human adenosine a2a receptor and may be used as, for example, anti-inflammatory agents in the treatment of repiratory diseases |
09/10/2002 | US6448230 Testis expressed polypeptide |
09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
09/10/2002 | US6448070 Recombinant plant viruses, especially their use as immunizing agents which carry antigenic sequences from mammalian or other animal pathogens and their use as a system for increased production of polypeptides of interest |
09/10/2002 | US6448043 Enterococcus faecalis EF040 and uses therefor |
09/10/2002 | US6448037 PgsA |
09/10/2002 | US6448036 ribB |
09/10/2002 | US6448035 Disorders mediated by disease states associated with suppressed immune function can be treated by administering a soluble form of the negative signaling lir |
09/10/2002 | US6448021 Cc-chemokine receptor 2 (ccr2) bound by an antibody or functional fragment to block binding of a ligand |
09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
09/10/2002 | US6447993 Protecting cats from infection by a broad range of fiv strains using a multi-subtype fiv vaccine. multi-subtype fiv vaccines comprising either cell free whole virus or cell lines infected with viruses and vaccinating cats |
09/10/2002 | US6447815 Heated alcohol extraction of herbs |
09/10/2002 | US6447810 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
09/10/2002 | US6447778 Peptide compositions for the treatment of HIV infection |
09/10/2002 | CA2128247C Vaccines based on streptokinase |
09/10/2002 | CA2087967C Cephalosporins and homologues, preparations and pharmaceutical compositions |
09/10/2002 | CA2053933C Nutritional composition comprising hydrolysed soluble fiber |
09/06/2002 | WO2002068655A1 Method of searching for remedy for hepatitis d |
09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
09/06/2002 | WO2002068637A2 Nucleic acid-based treatment of diseases or conditions related to west nile virus infection |
09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
09/06/2002 | WO2002068615A2 Activation of lymphocyte populations expressing nkg2d using anti-nkg2d antibodies and ligand derivatives |
09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
09/06/2002 | WO2002068476A2 Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders |
09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
09/06/2002 | WO2002068456A1 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
09/06/2002 | WO2002068438A2 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-0-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a |
09/06/2002 | WO2002068436A1 Avilamycin derivatives |
09/06/2002 | WO2002068424A1 Indole derivatives having an inhibitory effect on protein kinases |
09/06/2002 | WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors |
09/06/2002 | WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors |